'Investigator reports' presentation slideshows

FDA Final Rule & Revised CTEP Guidelines for Expedited Reporting of Adverse Events

FDA Final Rule & Revised CTEP Guidelines for Expedited Reporting of Adverse Events. National Cancer Institute Cancer Therapy Evaluation Program (CTEP) presents:. S. Percy Ivy, MD Associate Chief, Senior Investigator Investigational Drug Branch, National Cancer Institute ivyp@ctep.nci.nih.gov.

740 views • 51 slides